-+ 0.00%
-+ 0.00%
-+ 0.00%

BioMarin halts Phase 2 VOXZOGO dosing and enrollment in Turner syndrome, SHOX-deficiency and ACAN-deficiency trials

Reuters·03/16/2026 12:32:56

Please log in to view news